Wortmannin C - Compound Card

Wortmannin C

Select a section from the left sidebar

Wortmannin C

Structure
Zoomed Structure
  • Family: Fungi - Trichocomaceae
  • Kingdom: Fungi
  • Class: Alkaloid
    • Subclass: Cyclic Peptide
Canonical Smiles COC[C@@H]1OC(=O)/C(=C\N)/C2=C(O)C(=O)C3=C([C@]12C)[C@@H](OC(=O)C)C[C@@]1([C@@H]3CCC1=O)C
InChI InChI=1S/C23H27NO8/c1-10(25)31-13-7-22(2)12(5-6-14(22)26)16-18(13)23(3)15(9-30-4)32-21(29)11(8-24)17(23)20(28)19(16)27/h8,12-13,15,28H,5-7,9,24H2,1-4H3/b11-8-/t12-,13+,15+,22-,23-/m1/s1
InChIKey XHMOHVXNYNSALF-ATOQYJMLSA-N
Formula C23H27NO8
HBA 9
HBD 2
MW 445.47
Rotatable Bonds 3
TPSA 142.22
LogP 1.42
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 32
Formal Charge 0
Fraction CSP3 0.57
Exact Mass 445.17
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Talaromyces wortmannii Trichocomaceae Fungi 28567

Showing of synonyms

  • Bara R (2012). Natural Products from Endophytic Fungus Talaromyces wortmannii: Their Structure and mechanism of Actions. PhD Thesis, Institute for Pharmaceutical Biology and Biotechnology, University of Dusseldorf,2012, pp. 1-142.. [View]
Pubchem: 162817035

No compound-protein relationship available.

Structure

SMILES: C1OC(=O)C(=C)C(=CC2=O)C1C(CC3)=C2C(C34)CCC4=O

Level: 0

Mol. Weight: 445.47 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.04
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.890
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
-2.34

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.600
Plasma Protein Binding
57.59
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
8.290
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.590
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.500
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
6.690
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Toxic
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-62.270
Rat (Acute)
4.100
Rat (Chronic Oral)
2.770
Fathead Minnow
4.050
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
460.410
Hydration Free Energy
-3.050
Log(D) at pH=7.4
0.840
Log(P)
-0.26
Log S
-3.54
Log(Vapor Pressure)
-8.81
Melting Point
257.66
pKa Acid
4.01
pKa Basic
4.08

No predicted protein targets found for this compound.

Download SDF